Clear Harbor Asset Management’s West Pharmaceutical WST Stock Holding History

Clear Harbor Asset Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$280K	Buy	+780	New	+$238K	0.02%	376
2026 Q1	–	Sell	-11,897	Closed	-$3.27M	–	498
2025 Q4	$3.27M	Sell	11,897 -1,145	-9%	-$313K	0.22%	87
2025 Q3	$3.42M	Sell	13,042 -535	-4%	-$130K	0.24%	88
2025 Q2	$2.97M	Sell	13,577 -1,869	-12%	-$400K	0.22%	89
2025 Q1	$3.46M	Sell	15,446 -48	-0.3%	-$13.2K	0.27%	77
2024 Q4	$5.08M	Sell	15,494 -97	-0.6%	-$30.5K	0.4%	61
2024 Q3	$4.68M	Buy	15,591 +1,236	+9%	+$379K	0.38%	65
2024 Q2	$4.73M	Sell	14,355 -20	-0.1%	-$7.07K	0.41%	63
2024 Q1	$5.69M	Buy	14,375 +259	+2%	+$95.8K	0.5%	48
2023 Q4	$4.97M	Sell	14,116 -13	-0.1%	-$4.6K	0.46%	52
2023 Q3	$5.3M	Sell	14,129 -345	-2%	-$133K	0.55%	38
2023 Q2	$5.54M	Buy	14,474 +3,806	+36%	+$1.36M	0.54%	39
2023 Q1	$3.7M	Buy	+10,668	New	+$3.12M	0.38%	61

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Clear Harbor Asset Management's WST Position: Q2 2026 in Review

Clear Harbor Asset Management opened a new position in West Pharmaceutical (WST) in Q2 2026: 780 shares worth $280K. The stake represents 0.02% of the portfolio and ranks #376 among its holdings. This is a return to the name: Clear Harbor Asset Management previously reported a position in WST as recently as Q4 2025.

Clear Harbor Asset Management first reported a position in WST in Q1 2023 and has held it in 13 quarters since. The position peaked at $5.69M in Q1 2024. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Clear Harbor Asset Management held 780 shares of West Pharmaceutical worth $280K as of Q2 2026.
West Pharmaceutical was a new Clear Harbor Asset Management position in Q2 2026.
West Pharmaceutical made up 0.02% of Clear Harbor Asset Management's portfolio in Q2 2026, its #376 holding.
Clear Harbor Asset Management first reported a position in West Pharmaceutical in Q1 2023 and has held it in 13 quarters since.
Clear Harbor Asset Management's West Pharmaceutical position peaked at $5.69M in Q1 2024.
830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Clear Harbor Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.